Growth opportunities ImpediMed has a growing focus on expanding heart health, wellness, and weight management programs beyond breast cancer lymphedema, suggesting sales potential for devices and platform capabilities in these adjacent care pathways.

Pipeline conversion Management highlighted a large sales pipeline and emphasis on converting opportunities, indicating near-term upsell or cross-sell potential for clinicians already engaged with the SOZO platform.

Reimbursement expansion Strategic priority on expanding reimbursement could align with sales efforts to target hospital systems and clinics seeking broader coverage for BIS-based fluid monitoring and secondary lymphedema management.

Digital platform leverage SOZO Digital Health Platform and real-time BIS insights offer upsell opportunities to healthcare networks adopting digital survivorship and remote monitoring programs, increasing customer stickiness.

Cross-sell potential Existing customers in oncology and post-treatment care present avenues to introduce BIS-based analytics for weight management, GLP-1 therapy monitoring, and cardiovascular or fluid status tracking in related cohorts.